title: Concerns about injectable naltrexone for opioid dependence.
authors.affiliation: Open Society Institute, International Harm Reduction Development Program, New York, NY 10019, USA. dwolfe@sorosny.org
authors.forename: Daniel
authors.initials: D
authors.lastname: Wolfe
authors.forename: M Patrizia
authors.initials: MP
authors.lastname: Carrieri
authors.forename: Nabarun
authors.initials: N
authors.lastname: Dasgupta
authors.forename: Alex
authors.initials: A
authors.lastname: Wodak
authors.forename: Robert
authors.initials: R
authors.lastname: Newman
authors.forename: R Douglas
authors.initials: RD
authors.lastname: Bruce
mesh_terms: D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D006801:Humans; D007267:Injections; D009271:Naltrexone / Q000008:administration & dosage* / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D009293:Opioid-Related Disorders / Q000534:rehabilitation*
chemical_list: D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D009271:Naltrexone